Table 1 Demographic and clinical characteristics of nine patients treated with rituximab
Age (years) (mean (SD)) | 40.9 (11.1) |
(median (range)) | 41.5 (21.0-55.0) |
Disease duration (months) (mean (SD)) | 49.0 (73.1) |
(median (range)) | 24.0 (12-240) |
Female (number,%) | 8 (88.9) |
Male (number,%) | 1 (11.1) |
ANA positivity (number,%) | 9 (100) |
Anti-Scl70 positivity (number,%) | 6 (66.7) |
Follow-up (months)(mean (SD)) | 16.7 (12.6) |
(median (range)) | 12 (6-36) |